Med-Chemist : "Quintessential Medicinal Chemistry"
Saturday, September 6, 2014
Prana's PBT2 receives FDA Orphan Drug designation for treatment of Huntington disease
Prana's PBT2 receives FDA Orphan Drug designation for treatment of Huntington disease
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment